IMNN
IMNN
NASDAQ · Biotechnology

Imunon Inc

$0.59
-0.05 (-7.29%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +4,090.4% upside
Low Target $16.96
Average Target $24.74
High Target $28.19
Current Price $0.59
Current
$0.59
Target
$24.74
$16.96 $24.74 avg $28.19
Scenario Analysis
Bear Case
$16.96
2,772.6%
Low target
Base Case
$24.74
+4,090.4%
Avg target
Bull Case
$28.19
+4,674.7%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$4.38
-86.5% from high
52-Week Low
$0.81
+-27.1% from low
Target vs 52W High
$24.74
+464.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%